Financing
Net Change in Short-term Borrowings and Indebtedness to Subsidiaries
Merck & Co. Net Change in Short-term Borrowings and Indebtedness to Subsidiaries increased by 6973.3% to $1.06B in Q1 2026 compared to the prior quarter.
Analysis
StatementCash Flow Statement
SectionFinancing
First reportedQ1 2013
Last reportedQ1 2026May 4, 2026
Metric ID:
wfc_change_in_short_term_borrowings_and_subsidiary_debtHistorical Data
12 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$4.77B | $0.00 | -$3.00M | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $48.00M | $15.00M | $1.06B |
| QoQ Change | — | +100.0% | — | +100.0% | — | — | — | — | — | — | -68.8% | >999% |
| YoY Change | — | — | — | — | +100.0% | — | +100.0% | — | — | — | — | — |
Range-$4.77B – $1.06B
CAGR-42.1%
Avg YoY Growth+100.0%
Median YoY Growth+100.0%
Net Change in Short-term Borrowings and Indebtedness to Subsidiaries at Other Companies
Frequently Asked Questions
- What is Merck & Co.'s net change in short-term borrowings and indebtedness to subsidiaries?
- Merck & Co. (MRK) reported net change in short-term borrowings and indebtedness to subsidiaries of $1.06B in Q1 2026.